Pediatrix Medical (MD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $27.76, +2.59% vs the prior close of $27.06.
- Volume 479.10K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MD rises 2.6% to $27.76, a 52-week high. Closed at $27.76, +2.59% vs the prior close of $27.06. Day range $27.29–$27.78, opened at $27.29.
MD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MD rises 2.6% to $27.76, a 52-week high
- Closed at $27.76, +2.59% vs the prior close of $27.06. Day range $27.29–$27.78, opened at $27.29.
- Volume was 479.10K shares, 0.6x its 50-day average of 766.95K.
- Price is +5.0% vs its 50-day average ($26.44) and +18.1% vs its 200-day average ($23.50).
- 52-week range $16.02–$27.94; today's close sits at 98% of that range, 0.6% below the 52-week high.
Oct 14, 2026 — MD rises 1.7% to $27.06, a 1-month high
- Closed at $27.06, +1.69% vs the prior close of $26.61. Day range $26.46–$27.20, opened at $26.46.
- Volume was 1.16M shares, 1.5x its 50-day average of 774.73K.
- Price is +2.5% vs its 50-day average ($26.40) and +15.3% vs its 200-day average ($23.47).
- 52-week range $15.82–$27.94; today's close sits at 93% of that range, 3.1% below the 52-week high.
Oct 13, 2026 — MD dips 1.2% to $26.61
- Closed at $26.61, -1.15% vs the prior close of $26.92. Day range $26.48–$27.08, opened at $27.00.
- Volume was 461.10K shares, 0.6x its 50-day average of 779.92K — lighter than usual.
- Price is +1.0% vs its 50-day average ($26.35) and +13.5% vs its 200-day average ($23.45).
- 52-week range $15.82–$27.94; today's close sits at 89% of that range, 4.8% below the 52-week high.
Oct 12, 2026 — MD rises 1.1% to $26.92, a 1-month high, 3 up days in a row
- Closed at $26.92, +1.05% vs the prior close of $26.64. Day range $26.56–$27.04, opened at $26.64.
- Volume was 487.30K shares, 0.6x its 50-day average of 779.25K.
- Price is +2.2% vs its 50-day average ($26.35) and +14.9% vs its 200-day average ($23.42).
- 52-week range $15.70–$27.94; today's close sits at 92% of that range, 3.7% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — MD rises 1.5% to $26.64
- Closed at $26.64, +1.52% vs the prior close of $26.24. Day range $26.33–$26.86, opened at $26.35.
- Volume was 518.00K shares, 0.7x its 50-day average of 785.83K.
- Price is +1.1% vs its 50-day average ($26.34) and +13.9% vs its 200-day average ($23.39).
- 52-week range $15.70–$27.94; today's close sits at 89% of that range, 4.7% below the 52-week high.
Oct 8, 2026 — MD rises 1.6% to $26.24
- Closed at $26.24, +1.59% vs the prior close of $25.83. Day range $25.54–$26.35, opened at $25.70.
- Volume was 730.00K shares, 0.9x its 50-day average of 782.32K.
- Price is -0.4% vs its 50-day average ($26.34) and +12.3% vs its 200-day average ($23.37).
- 52-week range $15.70–$27.94; today's close sits at 86% of that range, 6.1% below the 52-week high.
Oct 7, 2026 — MD dips 0.7% to $25.83
- Closed at $25.83, -0.65% vs the prior close of $26.00. Day range $25.72–$26.40, opened at $25.81.
- Volume was 655.80K shares, 0.8x its 50-day average of 779.33K.
- Price is -2.0% vs its 50-day average ($26.35) and +10.6% vs its 200-day average ($23.35).
- 52-week range $15.70–$27.94; today's close sits at 83% of that range, 7.6% below the 52-week high.
Oct 6, 2026 — MD dips 0.4% to $26.00
- Closed at $26.00, -0.38% vs the prior close of $26.10. Day range $25.70–$26.51, opened at $26.27.
- Volume was 667.70K shares, 0.9x its 50-day average of 781.07K.
- Price is -1.4% vs its 50-day average ($26.37) and +11.5% vs its 200-day average ($23.33).
- 52-week range $15.70–$27.94; today's close sits at 84% of that range, 6.9% below the 52-week high.
Oct 5, 2026 — MD rises 0.5% to $26.10, 3 up days in a row
- Closed at $26.10, +0.50% vs the prior close of $25.97. Day range $25.59–$26.46, opened at $25.90.
- Volume was 953.20K shares, 1.2x its 50-day average of 772.67K.
- Price is -1.0% vs its 50-day average ($26.37) and +12.0% vs its 200-day average ($23.31).
- 52-week range $15.70–$27.94; today's close sits at 85% of that range, 6.6% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — MD rises 0.8% to $25.97
- Closed at $25.97, +0.82% vs the prior close of $25.76. Day range $25.67–$26.29, opened at $25.77.
- Volume was 616.40K shares, 0.8x its 50-day average of 772.44K.
- Price is -1.5% vs its 50-day average ($26.37) and +11.5% vs its 200-day average ($23.29).
- 52-week range $15.70–$27.94; today's close sits at 84% of that range, 7.1% below the 52-week high.
MD latest news & SEC filings
Every SEC filing by or about MD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 3, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 3, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $39.84M (prior year $39.26M) (+1.5% vs Jun 30, 2025)
- Diluted EPS: $0.49 (prior year $0.46) (+6.5% vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade MD
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: Jul 15, 2026, May 5, 2026, Feb 19, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.25% (largest 2.6%).
- Liquidity: about 757.26K shares (≈$21.02M) trade per day on average.
- 52-week position: $27.76 vs a range of $16.02–$27.94 (98% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Shirley A Weis sold 36,028 shares on May 13, 2026.
- Latest filings: 10-Q Aug 4, 2026; 8-K Aug 4, 2026; 8-K Jul 24, 2026.
- Share count: 81.25M shares outstanding (Jul 31, 2026), -6.7% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-Hospitals.
MD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 27.29 | 27.78 | 27.29 | 27.76 | 479.10K |
| Oct 14, 2026 | 26.46 | 27.20 | 26.46 | 27.06 | 1.16M |
| Oct 13, 2026 | 27.00 | 27.08 | 26.48 | 26.61 | 461.10K |
| Oct 12, 2026 | 26.64 | 27.04 | 26.56 | 26.92 | 487.30K |
| Oct 9, 2026 | 26.35 | 26.86 | 26.33 | 26.64 | 518.00K |
| Oct 8, 2026 | 25.70 | 26.35 | 25.54 | 26.24 | 730.00K |
| Oct 7, 2026 | 25.81 | 26.40 | 25.72 | 25.83 | 655.80K |
| Oct 6, 2026 | 26.27 | 26.51 | 25.70 | 26.00 | 667.70K |
| Oct 5, 2026 | 25.90 | 26.46 | 25.59 | 26.10 | 953.20K |
| Oct 2, 2026 | 25.77 | 26.29 | 25.67 | 25.97 | 616.40K |
| Oct 1, 2026 | 25.80 | 26.12 | 25.40 | 25.76 | 1.53M |
| Sep 30, 2026 | 26.14 | 26.51 | 25.64 | 25.73 | 779.50K |
| Sep 29, 2026 | 25.82 | 26.10 | 25.48 | 26.06 | 528.30K |
| Sep 28, 2026 | 26.23 | 26.82 | 25.85 | 25.93 | 629.30K |
| Sep 25, 2026 | 25.66 | 26.34 | 25.66 | 26.31 | 386.00K |
| Sep 24, 2026 | 26.25 | 26.25 | 25.55 | 25.66 | 732.60K |
| Sep 23, 2026 | 26.23 | 26.40 | 25.79 | 25.86 | 454.00K |
| Sep 22, 2026 | 25.61 | 26.49 | 25.61 | 26.35 | 818.00K |
| Sep 21, 2026 | 26.06 | 26.06 | 25.30 | 25.77 | 506.80K |
| Sep 18, 2026 | 25.50 | 25.97 | 25.18 | 25.93 | 2.06M |
About Pediatrix Medical
Pediatrix Medical (MD) is listed on the NYSE and classified by the SEC under “Services-Hospitals”. Its business address is in SUNRISE, FL. State of incorporation: FL. Fiscal year ends December 31. SEC CIK 893949.
MD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Laura A Linynsky | Director | Sep 14, 2026 |
| Thomas Mceachin | Director | Aug 14, 2026 |
| Kurt Douglas Newman | Director | Aug 14, 2026 |
| Mark S Ordan | Chief Executive Officer | Jun 3, 2026 |
| Michael A. Rucker | Director | Aug 14, 2026 |
| Guy P Sansone | Director | Aug 14, 2026 |
| John M. Jr. Starcher | Director | Aug 14, 2026 |
| Shirley A Weis | Director | Aug 14, 2026 |
| Sylvia Jean Young | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Haddock | EVP, GC & Corp Sec | Jun 24, 2026 |
| Mary Ann E Moore | EVP, GC, Chief Admin Off & Sec | Jun 10, 2026 |
| Don Gregory Neeb | EVP, Chief Invest & Strategy | Jun 3, 2026 |
| Mark S Ordan | Chief Executive Officer | Jun 3, 2026 |
| Kasandra H Rossi | EVP, CFO and Treasurer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 13, 2026 | Shirley A Weis | Sale | 36,028 | $23.75 |
| Dec 15, 2025 | Mark S Ordan | Sale | 23,000 | $22.41 |
| Nov 17, 2025 | Michael A. Rucker | Sale | 10,478 | $23.00 |
| Nov 6, 2025 | Laura A Linynsky | Sale | 10,000 | $21.65 |
MD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $165.39M | 1.94 | $271.09M |
| Dec 31, 2024 | — | $-99.07M | -1.19 | $206.57M |
| Dec 31, 2023 | — | $-60.41M | -0.73 | $137.32M |
| Dec 31, 2022 | — | $66.33M | 0.79 | $166.94M |
| Dec 31, 2021 | — | $130.96M | 1.53 | $76.74M |
Latest balance sheet: total assets $2.13B, total liabilities $1.25B, cash $288.88M (as of Jun 30, 2026).
MD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $24.71 |
| Jul 15, 2026 | 8-K Item 2.02 (results) | $25.88 |
| May 5, 2026 | 8-K Item 2.02 (results) | $20.83 |
| Feb 19, 2026 | 8-K Item 2.02 (results) | $19.30 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $21.08 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $12.92 |
| May 6, 2025 | 8-K Item 2.02 (results) | $14.48 |
| Feb 20, 2025 | 8-K Item 2.02 (results) | $17.23 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $13.31 |
| Nov 1, 2024 | 8-K Item 2.02 (results) | $15.21 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Hospitals
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.